IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 201–300 of 1,002
Bulati, M., Caruso, C., & Colonna‐Romano, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.04.001 · Cited by 123
GATA-3 regulates the self-renewal of long-term hematopoietic stem cells
Frelin, C., Herrington, R., Janmohamed, S., Barbara, M., Tran, G., Paige, C. J., Benveniste, P., Zuñiga-Pflücker, J.-C., Souabni, A., Busslinger, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2692 · Cited by 107
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Puig, I., Tenbaum, S. P., Chicote, I., Arqués, O., Martínez‐Quintanilla, J., Cuesta-Borràs, E., Ramírez, L., Gonzalo, P., Soto, A., Aguilar, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96393 · Cited by 123
“The most promising results have been reported in hematological tumors where mobilization of DTCs by different factors, such as G-CSF or IFN-α, sensitizes them to chemotherapy (49, 50).”
The mechanisms of pathological extramedullary hematopoiesis in diseases
Yang, X., Chen, D., Long, H., & Zhu, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03450-w · Cited by 127
Inflammatory signaling regulates hematopoietic stem and progenitor cell development and homeostasis
Collins, A., Mitchell, C. A., & Passegué, E. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201545 · Cited by 111
A KRAB/KAP1-miRNA Cascade Regulates Erythropoiesis Through Stage-Specific Control of Mitophagy
Barde, I., Rauwel, B., Marin-Florez, R. M., Corsinotti, A., Laurenti, E., Verp, S., Offner, S., Marquis, J., Kapopoulou, A., Vanicek, J., et al. (2013) · Science · doi:10.1126/science.1232398 · Cited by 111
“We induced Kap1 deletion by pIC injection 6 to 8 weeks after transplantation, and began our analyses at least 2 weeks later, so as to avoid effects linked to pIC injection per se (31).”
MethodSelf-citationRegulation of Tumor Cell Dormancy by Tissue Microenvironments and Autophagy
Sosa, M. S., Bragado, P., Debnath, J., & Aguirre-Ghiso, J. A. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1445-2_5 · Cited by 109
Bazhin, A. V., von Ahn, K., Fritz, J., Werner, J., & Karakhanova, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02129 · Cited by 104
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response
Qadir, A. S., Ceppi, P., Brockway, S., Law, C., Mu, L., Khodarev, N. N., Kim, J., Zhao, J. C., Putzbach, W., Murmann, A. E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.037 · Cited by 125
“While acute IFNa treatment promotes the proliferation of dormant hematopoietic stem cells in vivo (Essers et al., 2009), neither STAT1nor anyof the three targetgeneshavebeendirectly connected to cancer stemness.”
The Hematopoietic Bone Marrow Niche Ecosystem
Fröbel, J., Landspersky, T., Perçin, G. I., Schreck, C., Rahmig, S., Ori, A., Nowak, D., Essers, M. A. G., Waskow, C., & Oostendorp, R. A. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.705410 · Cited by 122
Self-citationLansdorp, P. M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.172 · Cited by 108
“Among environmental ‘toxins’, factors induced by viral or other infections, such as interferon alpha ( Essers et al, 2009 ), or factors stimulated by, for example, sustained psychological stress (Epel et al, 2004) should probably be included.”
BackgroundBruns, I., Cadeddu, R., Brueckmann, I., Fröbel, J., Geyh, S., Büst, S., Fischer, J., Roels, F., Wilk, C. M., Schildberg, F. A., et al. (2012) · Blood · doi:10.1182/blood-2011-04-347484 · Cited by 119
Self-citationPetrillo, C., Thorne, L. G., Unali, G., Schiroli, G., Giordano, A. M. S., Piras, F., Cuccovillo, I., Petit, S. J., Ahsan, F., Noursadeghi, M., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.008 · Cited by 106
“There is increasing evidence that HSPC are responsive to type-I interferon (IFN)-mediated innate immune signaling (Essers et al., 2009; Haas et al., 2015; Hirche et al., 2017; Nagai et al., 2006).”
BackgroundHasselbalch, H. C., & Holmström, M. O. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0700-2 · Cited by 112
NF-Y is necessary for hematopoietic stem cell proliferation and survival
Bungartz, G., Land, H., Scadden, D. T., & Emerson, S. G. (2011) · Blood · doi:10.1182/blood-2011-06-359406 · Cited by 107
Celià-Terrassa, T., Liu, D. D., Choudhury, A., Hang, X., Wei, Y., Zamalloa, J., Alfaro‐Aco, R., Chakrabarti, R., Jiang, Y., Koh, B. I., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3533 · Cited by 110
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases
Chiba, Y., Mizoguchi, I., Hasegawa, H., Ohashi, M., Orii, N., Nagai, T., Sugahara, M., Miyamoto, Y., Xu, M., Owaki, T., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2724-5 · Cited by 114
Calcagno, D. M., Ng, R. P., Toomu, A., Zhang, C., Huang, K., Aguirre, A. D., Weissleder, R., Daniels, L. B., Fu, Z., & King, K. R. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz1974 · Cited by 101
Made to order: emergency myelopoiesis and demand-adapted innate immune cell production
Swann, J. W., Olson, O. C., & Passegue, E. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00998-7 · Cited by 116
“In particular, IL-1 and IFNγ signalling drive clonal expansion of Tet2 -mutant and Dnmt3a -mutant HSCs, respectively, in murine models 179,181 .”
InfluentialGATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry
Ku, C.-J., Hosoya, T., Maillard, I., & Engel, J. D. (2012) · Blood · doi:10.1182/blood-2011-07-366070 · Cited by 101
A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland
Cai, S., Kalisky, T., Sahoo, D., Dalerba, P. D., Feng, W., Lin, Y., Qian, D., Kong, A., Yu, J. J., Wang, F., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.11.007 · Cited by 114
“In the hematopoietic system, HSCs rely on p21 (Cheng et al., 2000) and p57 (Matsumoto et al., 2011) to be maintained at the quiescent state and can be activated by interferon-a (IFN-a) (Essers et al., 2009).”
BackgroundInflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Hemmati, S., Haque, T., & Gritsman, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00265 · Cited by 101
“Short-term IFN-α treatment induced most hematopoietic stem and progenitor cells (HSPCs) in mice to exit the quiescent state and enter active cell cycling (23).”
BackgroundInnate Immune Memory and the Host Response to Infection
Sherwood, E. R., Burelbach, K. R., McBride, M. A., Stothers, C. L., Owen, A. M., Hernandez, A., Patil, N. K., Williams, D. L., & Bohannon, J. K. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101058 · Cited by 117
Chronic Bystander Infections and Immunity to Unrelated Antigens
Stelekati, E., & Wherry, E. J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.001 · Cited by 104
“Sustained production of cytokines including type I and type II IFN during chronic infections affects proliferation and differentiation of hematopoietic stem cells (Essers et al., 2009; Baldridge et al., 2010).”
To wake up cancer stem cells, or to let them sleep, that is the question
Takeishi, S., & Nakayama, K. I. (2016) · Cancer Science · doi:10.1111/cas.12958 · Cited by 102
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
Sistigu, A., Musella, M., Galassi, C., Vitale, I., & Maria, R. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02166 · Cited by 110
Training the fetal immune system through maternal inflammation—a layered hygiene hypothesis
Apostol, A. C., Jensen, K. D. C., & Beaudin, A. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00123 · Cited by 96
Kruta, M., Sunshine, M. J., Chua, B. A., Fu, Y., Chawla, A., Dillingham, C. H., Hidalgo San Jose, L., De Jong, B., Zhou, F. J., & Signer, R. A. J. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.07.009 · Cited by 100
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Nevius, E., Gomes, A. C., & Pereira, J. P. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8520-9 · Cited by 113
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia
Fang, J., Bolanos, L. C., Choi, K., Liu, X., Christie, S., Akunuru, S., Kumar, R., Wang, D., Chen, X., Greis, K. D., et al. (2017) · Nature Immunology · doi:10.1038/ni.3654 · Cited by 99
Bromberg, O., Frisch, B. J., Weber, J. M., Porter, R. L., Civitelli, R., & Calvi, L. M. (2012) · Blood · doi:10.1182/blood-2011-09-377853 · Cited by 111
The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells
Sirin, O., Lukov, G. L., Mao, R., Conneely, O. M., & Goodell, M. A. (2010) · Nature Cell Biology · doi:10.1038/ncb2125 · Cited by 96
“Nurr1 may have a similar role in HSCs during inflammatory stres”
The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease
Morales-Mantilla, D. E., & King, K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0139-3 · Cited by 99
An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion
Baumgartner, C., Toifl, S., Farlik, M., Halbritter, F., Scheicher, R., Fischer, I., Sexl, V., Bock, C., & Baccarini, M. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.003 · Cited by 96
Sampaio, M. M., Santos, M. L. C., Marques, H. S., Gonçalves, V. L. D. S., Araújo, G. R. L., Lopes, L. W., Apolonio, J. S., Silva, C. S., Santos, L. K. D. S., Cuzzuol, B. R., et al. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i2.69 · Cited by 117
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
El Hajj, H., El-Sabban, M., Hasegawa, H., Zaatari, G., Ablain, J., Saab, S. T., Janin, A., Mahfouz, R., Nasr, R., Kfoury, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101095 · Cited by 94
“In addition, IFN- forces stem cells into the cell cycle (Essers et al., 2009), possibly rendering them more susceptible to As2O3.”
BackgroundHematopoietic stem cell fate through metabolic control
Ito, K., & Ito, K. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.05.005 · Cited by 105
Grigoriou, M., Banos, A., Filia, A., Pavlidis, P., Giannouli, S., Karali, V., Nikolopoulos, D., Pieta, A., Bertsias, G. K., Verginis, P., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215782 · Cited by 104
Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
Duncan, C. J. A., Randall, R. E., & Hambleton, S. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.08.017 · Cited by 100
“In addition, a range of defects in haematopoietic stem cell (HSC) maintenance [80,81], immune cell number [e.”
Epigenetic Regulators as the Gatekeepers of Hematopoiesis
Rodrigues, C. P., Shvedunova, M., & Akhtar, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.015 · Cited by 107
Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1
Renders, S., Svendsen, A. F., Panten, J., Rama, N., Maryanovich, M., Sommerkamp, P., Ladel, L., Redavid, A. R., Gibert, B., Lazare, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20801-0 · Cited by 103
Self-citationRegulation of stress-induced hematopoiesis
Zhao, J. L., & Baltimore, D. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000149 · Cited by 87
Akinduro, O., Weber, T., Ang, H. Y.-K., Haltalli, M. L. R., Ruivo, N., Duarte, D., Rashidi, N. M., Hawkins, E. D., Duffy, K. R., & Celso, C. L. (2018) · Nature Communications · doi:10.1038/s41467-017-02376-5 · Cited by 104
The hematopoietic stem cell niche—home for friend and foe?
Krause, D. S., Scadden, D. T., & Preffer, F. I. (2012) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21066 · Cited by 113
Transcriptome Analysis Identifies Regulators of Hematopoietic Stem and Progenitor Cells
Gazit, R., Garrison, B. S., Rao, T. N., Shay, T., Costello, J., Ericson, J., Kim, F., Collins, J. J., Regev, A., Wagers, A. J., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.07.004 · Cited by 99
Diet‐induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow
van den Berg, S. M., Seijkens, T. T. P., Kusters, P. J. H., Beckers, L., den Toom, M., Smeets, E., Levels, J. H. M., de Winther, M. P. J., & Lutgens, E. (2016) · The FASEB Journal · doi:10.1096/fj.201500175 · Cited by 101
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
Epperly, R., Gottschalk, S. M., & Velasquez, M. P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00262 · Cited by 101
Cruz-Rivera, P. C. D. L., Kanchwala, M., Liang, H., Kumar, A., Wang, L., Xing, C., & Schoggins, J. W. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701214 · Cited by 100
Aging-induced IL27Ra signaling impairs hematopoietic stem cells
He, H., Xu, P., Zhang, X., Liao, M., Dong, Q., Cong, T., Tang, B., Yang, X., Ye, M., Chang, Y., et al. (2020) · Blood · doi:10.1182/blood.2019003910 · Cited by 94
Li, Y., Kong, W., Yang, W., Patel, R. M., Casey, E. B., Okeyo-Owuor, T., White, J. M., Porter, S. N., Morris, S. A., & Magee, J. A. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.08.001 · Cited by 88
Li, X.-D., Chiu, Y., Ismail, A. S., Behrendt, C. L., Wight‐Carter, M., Hooper, L. V., & Chen, Z. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107114108 · Cited by 105
Staal, F. J. T., & Luis, T. C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22467 · Cited by 86
“It is currently unclear why this is, but perhaps the effects of interferons on very dormant populations of HSC [Essers et al., 2009] may mask some of the otherwise discernable effects.”
BackgroundSIRT1 regulates metabolism and leukemogenic potential in CML stem cells
Abraham, A., Qiu, S., Chacko, B. K., Li, H., Paterson, A., He, J., Agarwal, P., Shah, M., Welner, R., Darley-Usmar, V. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127080 · Cited by 90
MacNamara, K. C., Jones, M., Martin, O., & Winslow, G. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028669 · Cited by 87
Quiescence regulators for hematopoietic stem cell
Li, J. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.008 · Cited by 111
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation
Knudsen, K. J., Rehn, M., Hasemann, M. S., Rapin, N., Bagger, F. O., Ohlsson, E., Willer, A., Frank, A.-K., Søndergaard, E., Jendholm, J., et al. (2015) · Genes & Development · doi:10.1101/gad.268409.115 · Cited by 98
PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress
Chavez, J. S., Rabe, J. L., Loeffler, D., Higa, K. C., Hernandez, G., Mills, T. S., Ahmed, N., Gessner, R. L., Ke, Z., Idler, B. M., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201169 · Cited by 91
Metastatic cancer stem cells: from the concept to therapeutics.
Liao, W., Ye, Y., Deng, Y., Bian, X., & Ding, Y.-Q. (2014) · Europe PMC (PubMed Central) · Cited by 108
Regulation of emergency granulopoiesis during infection
Paudel, S., Ghimire, L., Jin, L., Jeansonne, D. P., & Jeyaseelan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961601 · Cited by 102
“Later, two elegant reports confirmed that IFN-a stimulates the exit and proliferation of HSCs in two different models (96, 97).”
BackgroundResultThe cytokine network in acute myeloid leukemia
Luciano, M., Krenn, P. W., & Horejs‐Hoeck, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1000996 · Cited by 98
“While T cells obtained from AML patients at primary diagnosis exhibit increased IFN-g production, strongly reduced levels of IFN-g were observed in CD8+ T cells from patients who developed relapsed AML after allogeneic HCT (allo-HCT), whereas patients without relapse did not show reduced IFN-g production (169).”
BackgroundInfluentialTomasello, E., Pollet, É., Manh, T. V., Uzé, G., & Dalod, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00526 · Cited by 94
“Acute versus chronic exposure to IFN-I can lead to strikingly opposite effects on a given cell type (13, 14, 231) .”
Backgroundvan der Wath, R. C., Wilson, A., Laurenti, E., Trumpp, A., & Liò, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006972 · Cited by 83
Self-citationKon, A., Yamazaki, S., Nannya, Y., Kataoka, K., Ota, Y., Nakagawa, M. M., Yoshida, K., Shiozawa, Y., Morita, M., Yoshizato, T., et al. (2017) · Blood · doi:10.1182/blood-2017-01-762393 · Cited by 95
“We chose Vav1-Cre transgenic mice, instead of Mx1-Cre mice, as a Cre deleter strain to induce constitutive and hematopoietic specific Cre expression(25) to exclude the pro-proliferative effects of interferon.(26,27) Mice heterozygous for the floxed Srsf2P95H allele were crossed with Vav1-Cre mice to obtain a cohort of…”
MethodChemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration
Clapes, T., Polyzou, A., Prater, P., Sagar, Morales‐Hernández, A., Ferrarini, M. G., Kehrer, N., Lefkopoulos, S., Bergo, V., Hummel, B., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00707-9 · Cited by 94
Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling
King, K. Y., Baldridge, M. T., Weksberg, D. C., Chambers, S. M., Lukov, G. L., Wu, S., Boles, N. C., Jung, S. Y., Qin, J., Liu, D., et al. (2011) · Blood · doi:10.1182/blood-2011-01-328682 · Cited by 88
Chen, Z., Amro, E. M., Becker, F., Hölzer, M., Rasa, S. M. M., Njeru, S. N., Han, B., Di Sanzo, S., Chen, Y., Tang, D., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181505 · Cited by 86
“However, changes in surface marker expression could influence the quantification of HSCs and MPPs in response to LPS-induced inflammation, as such changes have been described in response to interferon stimulation in vivo (Essers et al., 2009).”
BackgroundMesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia
Waclawiczek, A., Hamilton, A., Rouault‐Pierre, K., Abarrategi, A., Albornoz, M. G., Miraki‐Moud, F., Bah, N. K., Gribben, J. G., Fitzgibbon, J., Taussig, D. C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133187 · Cited by 91
Tie2-expressing monocytes (TEMs): Novel targets and vehicles of anticancer therapy?
Palma, M. D., & Naldini, L. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.04.001 · Cited by 96
Stem Cells in Toxicology: Fundamental Biology and Practical Considerations
Kang, K., & Trosko, J. E. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq370 · Cited by 88
Normal Hematopoiesis Is a Balancing Act of Self-Renewal and Regeneration
Olson, O. C., Kang, Y.-A., & Passegué, E. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035519 · Cited by 76
A matter of life and death: stem cell survival in tissue regeneration and tumour formation
Soteriou, D., & Fuchs, Y. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.122 · Cited by 87
The hematopoietic stem cell niche
Park, D., Sykes, D., & Scadden, D. T. (2011) · Frontiers in bioscience · doi:10.2741/3913 · Cited by 92
Chomel, J., & Turhan, A. G. (2011) · Oncotarget · doi:10.18632/oncotarget.333 · Cited by 96
“Furthermore, in vivo mouse models are suggestive of its potential to activate quiescent hematopoietic stem cells [100].”
BackgroundSpivak, J. L. (2019) · Blood · doi:10.1182/blood.2018834044 · Cited by 95
Grinenko, T., Arndt, K., Portz, M., Mende, N., Günther, M., Cosgun, K. N., Alexopoulou, D., Lakshmanaperumal, N., Henry, I., Dahl, A., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131115 · Cited by 83
“Furthermore, HSCs that are biased toward the development of either lymphoid or myeloid cells respond differently to stimulation with IFN(Essers et al., 2009) or TGF- (Challen et al., 2010).”
BackgroundResistance to Imatinib: Mutations and Beyond
Rosée, P. G. L., & Deininger, M. W. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.06.005 · Cited by 86
Signal transduction therapy of cancer
Levitzki, A., & Klein, S. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.04.001 · Cited by 103
FGF signaling facilitates postinjury recovery of mouse hematopoietic system
Zhao, M., Ross, J. T., Itkin, T., Perry, J. M., Venkatraman, A., Haug, J. S., Hembree, M. J., Deng, C.-X., Lapidot, T., He, X. C., et al. (2012) · Blood · doi:10.1182/blood-2011-11-393991 · Cited by 84
Lu, M., Zhang, W., Li, Y., Berenzon, D., Wang, X., Wang, J., Mascarenhas, J., Xu, M., & Hoffman, R. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.03.005 · Cited by 80
“Recently, however, IFNa has been shown in a murine system to also be capable of promoting cycling of quiescent hematopoietic stem cells, indicating that IFNa might differentially affect cells belonging to different stages along the hematopoietic cellular hierarchy [37,38].”
Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration
Qi, L., Martin-Sandoval, M. S., Merchant, S., Gu, W., Eckhardt, M., Mathews, T. P., Zhao, Z., Agathocleous, M., & Morrison, S. J. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.07.011 · Cited by 91
Self‐priming determines high type I IFN production by plasmacytoid dendritic cells
Kim, S., Kaiser, V., Beier, E., Bechheim, M., Guenthner‐Biller, M., Ablasser, A., Berger, M., Endres, S., Hartmann, G., & Hornung, V. (2014) · European Journal of Immunology · doi:10.1002/eji.201343806 · Cited by 79
Yu, S., Cui, K., Jothi, R., Zhao, D.-M., Jing, X., Zhao, K., & Xue, H.-H. (2011) · Blood · doi:10.1182/blood-2010-09-306563 · Cited by 80
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
Ohlsson, E., Schuster, M. B., Hasemann, M. S., & Porse, B. T. (2015) · Leukemia · doi:10.1038/leu.2015.324 · Cited by 92
Lee, J.-M., Govindarajah, V., Goddard, B., Hinge, A., Muench, D. E., Filippi, M.-D., Aronow, B., Cancelas, J. A., Salomonis, N., Grimes, H. L., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170690 · Cited by 81
“…our data indicate that the effects of obesity on the HSC compartment do not mimic the effects of acute and chronic inflammatory conditions, which are associated with HSC cell cycle activation and rapid functional exhaustion (Essers et al., 2009; Baldridge et al., 2010; Esplin et al., 2011).”
BackgroundAntigen presentation safeguards the integrity of the hematopoietic stem cell pool
Hernández-Malmierca, P., Vonficht, D., Schnell, A., Uckelmann, H. J., Bollhagen, A., Mahmoud, M. A. A., Landua, S.-L., van der Salm, E., Trautmann, C. L., Raffel, S., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.007 · Cited by 86
Self-citationExpansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis
Arimoto, K., Miyauchi, S., Troutman, T. D., Zhang, Y., Liu, M., Stoner, S. A., Davis, A. G., Fan, J.-B., Huang, Y.-J., Yan, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35348-5 · Cited by 91
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling
Rossi, L., Salvestrini, V., Ferrari, D., Di Virgilio, F., & Lemoli, R. M. (2012) · Blood · doi:10.1182/blood-2012-04-422378 · Cited by 80
Schürch, C. M., Riether, C., Amrein, M. A., & Ochsenbein, A. F. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121229 · Cited by 87
“First, CTLs were able to eliminate LSCs 18 h after transfer in vivo, a time period that is sufficient for HSCs and LSCs to migrate to the niche (Colvin et al., 2007; Bhattacharya et al., 2009; Xie et al., 2009; Capron et al., 2010).”
BackgroundInfluentialThe bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
Greim, H. A., Kaden, D. A., Larson, R. A., Palermo, C. M., Rice, J. M., Ross, D., & Snyder, R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12362 · Cited by 89
Inflammatory bone marrow microenvironment
Leimkühler, N. B., & Schneider, R. K. (2019) · Hematology · doi:10.1182/hematology.2019000045 · Cited by 82
Velasco-Hernandez, T., Säwén, P., Bryder, D., & Cammenga, J. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.06.002 · Cited by 79
“The Immunophenotype of HSPCs Is Transiently Perturbed Following pIpC Administration Interferon signaling has previously been shown to enhance proliferation of HSPCs in vivo (Baldridge et al., 2010; Essers et al., 2009).”
BackgroundKleppe, M., Spitzer, M. H., Li, S., Hill, C. E., Dong, L., Papalexi, E., Groote, S. D., Bowman, R. L., Keller, M., Koppikar, P., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.08.011 · Cited by 85
“Previous studies have shown that Sca1 expression increases upon IFN-a exposure of LSKs (Essers et al., 2009; Morcos et al., 2017).”
BackgroundInfluentialNeutrophils in cardiovascular disease: warmongers, peacemakers, or both?
Sreejit, G., Johnson, J., Jaggers, R. M., Dahdah, A., Murphy, A. J., Hanssen, N. M. J., & Nagareddy, P. R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab302 · Cited by 90
Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis
De Blander, H., Morel, A.-P., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 72
Current challenges in metastasis research and future innovation for clinical translation
Parker, A. L., Benguigui, M., Fornetti, J., Goddard, E. T., Lucotti, S., Insua‐Rodríguez, J., & Wiegmans, A. P. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10144-5 · Cited by 89
Type I interferon is required for T helper (Th) 2 induction by dendritic cells
Webb, L. M., Lundie, R. J., Borger, J. G., Brown, S. L., Connor, L. M., Cartwright, A. N. R., Dougall, A. M., Wilbers, R. H. P., Cook, P. C., Jackson-Jones, L. H., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695345 · Cited by 90
“In addition, IFN-I production was also detected in FLDCs exposed to the T2 ribonuclease (RNase) omega-1 (Everts et al, 2009; Wilbers et al, 2017), which is the major Th2 immunostimulatory factor in, and one of the most abundant components of, S. mansoni egg secretions (Cass et al, 2007; Fig 1F).”
BackgroundKhandanpour, C., Sharif-Askari, E., Vassen, L., Gaudreau, M.-C., Zhu, J., Paul, W. E., Okayama, T., Kosan, C., & Möröy, T. (2010) · Blood · doi:10.1182/blood-2010-04-280305 · Cited by 78
Buechler, M. B., Teal, T. H., Elkon, K. B., & Hamerman, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202739 · Cited by 81
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.
Schemionek, M., Elling, C., Steidl, U., Bäumer, N., Hamilton, A., Spieker, T., Göthert, J. R., Stehling, M., Wagers, A., Huettner, C. S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215376 · Cited by 80
King, B., Boccalatte, F. E., Moran-Crusio, K., Wolf, E., Wang, J., Kayembe, C., Lazaris, C., Yu, X., Aranda-Orgillés, B., Lasorella, A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3559 · Cited by 95
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.